Biofrontera's top three insider shareholders as of March 23, 2026 are Hermann Luebbert (Ceo Chairman, 290.21K shares), Eugene Frederick Leffler (Chief Financial Officer, 175.00K shares), Erica L. Monaco (Chief Executive Officer, 133.03K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Hermann Luebbert | Ceo Chairman | 290,211 | 0 | 06 Mar, 2026 |
| Eugene Frederick Leffler | Chief Financial Officer | 175,000 | 0 | 06 Mar, 2026 |
| Erica L. Monaco | Chief Executive Officer | 133,025 | 0 | 22 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Mar, 2026 | George Patrick Jones | Restricted Stock Units | A | 50,000 | $0.00 | 50,000 | D | A |
| 04 Mar, 2026 | Beth J. Hoffman | Employee stock option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 04 Mar, 2026 | Kevin Daniel Weber | Employee stock option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 05 Mar, 2026 | Eugene Frederick Leffler | Common Stock | A | 87,500 | - | 175,000 | D | M |
| 05 Mar, 2026 | Hermann Luebbert | Common Stock | A | 137,500 | - | 290,211 | D | M |
| 04 Mar, 2026 | Heikki Lanckriet | Employee stock option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 04 Mar, 2026 | Hermann Luebbert | Restricted Stock Units | A | 125,000 | $0.00 | 125,000 | D | A |
| 04 Mar, 2026 | George Patrick Jones | Employee stock option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 04 Mar, 2026 | Eugene Frederick Leffler | Restricted Stock Units | A | 62,500 | $0.00 | 62,500 | D | A |
| 04 Mar, 2026 | Eugene Frederick Leffler | Employee stock option (right to buy) | A | 62,500 | $0.00 | 62,500 | D | A |
| 04 Mar, 2026 | Hermann Luebbert | Employee stock option (right to buy) | A | 125,000 | $0.00 | 125,000 | D | A |
| 05 Mar, 2026 | Eugene Frederick Leffler | Restricted Stock Units | D | 87,500 | $0.00 | 0 | D | M |
| 05 Mar, 2026 | Hermann Luebbert | Restricted Stock Units | D | 137,500 | $0.00 | 0 | D | M |
| 16 Sep, 2025 | Ag Biofrontera | Series D Convertible Preferred Stock | A | 3,019 | - | 3,019 | D | P |
| 22 Jul, 2025 | Heikki Lanckriet | Employee stock option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 22 Jul, 2025 | Kevin Daniel Weber | Employee stock option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 22 Jul, 2025 | Beth J. Hoffman | Employee stock option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 10 Sep, 2025 | Eugene Frederick Leffler | Common Stock | A | 87,500 | - | 87,500 | D | M |
| 10 Sep, 2025 | Hermann Luebbert | Common Stock | A | 137,500 | - | 152,711 | D | M |
| 15 Sep, 2025 | George Patrick Jones | Employee stock option (right to buy) | A | 100,000 | $0.00 | 100,000 | D | A |